---
figid: PMC11121530__ijms-25-05190-g001
pmcid: PMC11121530
image_filename: PMC11121530__ijms-25-05190-g001.jpg
figure_link: /pmc/articles/PMC11121530/figure/F1/
number: Figure 1
figure_title: Mechanism of action of metformin in reducing diabetes.
caption: 'Mechanism of action of metformin in reducing diabetes. Metformin regulates
  critical components of glucose metabolism and insulin signaling pathways in various
  tissues. Upward arrow indicates increase and downward arrow indicates decrease.
  AMP: adenosine monophosphate; AMPK: AMP-activated protein kinase; CREB: cyclic AMP
  response element -binding protein; PEPCK: phosphoenolpyruvate carboxykinase; G6Pase:
  Glucose-6-phosphatase; GLUT4: glucose transporter 4; and GLP1: glucagon-like peptide'
article_title: 'Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in
  the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19:
  A Narrative Review'
citation: Trevor J. Plowman, et al. Int J Mol Sci. 2024 May;25(10).
year: '2024'
pub_date: 2024-5-
epub_date: 2024-5-10
doi: 10.3390/ijms25105190
journal_title: International Journal of Molecular Sciences
journa_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords:
- metformin
- inflammation
- COVID-19
- diabetes
- oxidative stress
---
